EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Hospital specificity, region specificity, and fluconazole resistance of Candida albicans bloodstream isolates






Journal of Clinical Microbiology 36(6): 1518-1529

Hospital specificity, region specificity, and fluconazole resistance of Candida albicans bloodstream isolates

In a survey of bloodstream infection (BSI) isolates across the continental United States, 162 Candida albicans isolates were fingerprinted with the species-specific probe Ca3 and the patterns were analyzed for relatedness with a computer-assisted system. The results demonstrate that particular BSI strains are more highly concentrated in particular geographic locales and that established BSI strains are endemic in some, but not all, hospitals in the study and undergo microevolution in hospital settings. The results, however, indicate no close genetic relationship among fluconazole-resistant BSI isolates in the collection, either from the same geographic locale or the same hospital. This study represents the first of three fingerprinting studies designed to analyze the origin, genetic relatedness, and drug resistance of Candida isolates responsible for BSI.


Accession: 003161839

PMID: 9620370



Related references

Karlowsky, J.A.; Balko, T.V.; Hoban, D.J.; Zhanel, G.G., 1998: Stability of fluconazole resistance phenotype in clinical isolates of fluconazole-resistant Candida albicans. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 38: 496

Maebashi, K.; Kudoh, M.; Nishiyama, Y.; Makimura, K.; Uchida, K.; Mori, T.; Yamaguchi, H., 2002: A novel mechanism of fluconazole resistance associated with fluconazole sequestration in Candida albicans isolates from a myelofibrosis patient. A series of 10 strains of Candida albicans, from TIMM 3309 to TIMM 3318, were repeatedly isolated in one myelofibrosis-complicated patient with recurrent candidaemia [Japan]. The latter five isolates, from TIMM 3314 to TIMM 3318, became suddenly r...

Wirsching, S.; Michel, S.; Morschhäuser, J., 2000: Targeted gene disruption in Candida albicans wild-type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates. Resistance of the pathogenic yeast Candida albicans to the antifungal agent fluconazole is often caused by active drug efflux out of the cells. In clinical C. albicans strains, fluconazole resistance frequently correlates with constitutive activat...

Karlowsky, J.A.; Balko, T.V.; Hoban, D.J.; Kabani, A.M.; Zhanel, G.G., 1998: Northern analysis of multidrug resistance efflux pump and target site mRNA in fluconazole-sensitive and fluconazole-resistant oropharyngeal isolates of Candida albicans collected from AIDS patients. Abstracts of the General Meeting of the American Society for Microbiology 98: 529-530

Arthington Skaggs, B.A.; Ciblak, M.A.; Lee, W.; Frade, J.P.; Warnock, D.W., 2001: Visual reading of MIC endpoints Are we over-estimating fluconazole resistance among Candida tropicalis bloodstream isolates?. Background: We detected a high rate of fluconazole resistance among C. tropicalis bloodstream isolates when tested by the NCCLS M27-A microdilution procedure with visual endpoint readings. To establish whether these results were reliable, MICs wer...

Lee, I.; Zaoutis, T.E.; Fishman, N.O.; Morales, K.H.; Nachamkin, I.; Lautenbach, E., 2010: Risk factors for fluconazole resistance in patients with Candida glabrata bloodstream infection: potential impact of control group selection on characterizing the association between previous fluconazole use and fluconazole resistance. Although Candida glabrata is an emerging infection, risk factors for fluconazole resistance in patients with C glabrata bloodstram infection (BSI) have not been well elucidated. A case-control study was conducted to evaluate the primary risk facto...

Posteraro, B.; Martucci, R.; L.S.rda, M.; Fiori, B.; Sanglard, D.; D.C.rolis, E.; Florio, A.Rita.; Fadda, G.; Sanguinetti, M., 2009: Reliability of the Vitek 2 yeast susceptibility test for detection of in vitro resistance to fluconazole and voriconazole in clinical isolates of Candida albicans and Candida glabrata. The Vitek 2 yeast susceptibility test was evaluated by testing 122 Candida isolates against fluconazole and voriconazole. Excellent categorical agreement with the CLSI broth microdilution method was observed (97.5% for both the azoles). Moreover,...

Ruhnke M.; Eigler A.; Geiseler B., 1992: Fluconazole resistance in candida albicans isolates from patients with aids. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : b128

D.L.gu, A.; Saddi, M.; Cardia, M.Cristina.; Borgna, R.; Sanna, C.; Saddi, B.; Maccioni, E., 2005: In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans. Objectives: The aim of this study was to investigate the in vitro antifungal activity of an isothiosemicarbazone cyclic analogue against isolates of Candida spp. including fluconazole-resistant Candida albicans. Methods: We investigated the activi...

Pfaller, M.A.; Castanheira, M.; Lockhart, S.R.; Ahlquist, A.M.; Messer, S.A.; Jones, R.N., 2012: Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata. The echinocandin class of antifungal agents is considered to be the first-line treatment of bloodstream infections (BSI) due to Candida glabrata. Recent reports of BSI due to strains of C. glabrata resistant to both fluconazole and the echinocandi...